Nonalcoholic Steatohepatitis (NASH) Market Status and Forecast in Global by Product Type and End-user and Regions(Countries) 2016-2026 (COVID-19 Version)

SKU ID :99ST-18153163 | Published Date: 30-Apr-2021 | No. of pages: 136
TABLE OF CONTENTS 1 INDUSTRY OVERVIEW 1.1 Nonalcoholic Steatohepatitis (NASH) Industry 1.1.1 Nonalcoholic Steatohepatitis (NASH) Overview 1.1.2 Terminology Definition in the Report 1.1.2.1 Capacity 1.1.2.2 Sales Volume 1.1.2.3 Sales Revenue 1.1.2.4 Ex-factory Price & Sales Price 1.1.2.5 Cost 1.1.2.6 Gross Margin 1.2 Products & Services Overview Scope 1.3 Nonalcoholic Steatohepatitis (NASH) in the Industry Chain 1.4 Industry Dynamics & Regulations 1.5 Global Market Overview 2 UPSTREAM & MANUFACTURING 2.1 Raw Materials / Components 2.2 Procurement Methods & Channels 2.3 Cost Structure & Manufacturing 2.4 Industry Capacity Overview 2.5 Production Distribution by Geography 2.5.1 Production in Major Regions / Countries 2.5.2 Trade Flow Overview 3 PRODUCT SEGMENT 3.1 Product Segmentation Market (2017 to 2021E) 3.1.1 Weight Loss Treatment Market 3.1.2 Insulin-Sensitizing Agents Market 3.1.3 Lipid-Lowering Drugs Market 3.1.4 Antioxidants Market 3.1.5 Others Market 3.2 Market Status 4 APPLICATION / END-USE SEGMENT 4.1 Application Segmentation Market (2016 to 2021E) 4.1.1 Hospitals Market 4.1.2 Clinics Market 4.1.3 Research Institute Market 4.1.4 Others Market 4.2 Market Status 5 NORTH AMERICA 5.1 North America Market Growth 5.2 North America Market by Countries 5.3 Major Countries Market Growth 5.3.1 United States Market Size and Growth (2016-2021E) 5.3.2 Canada Market Size and Growth (2016-2021E) 5.3.3 Mexico Market Size and Growth (2016-2021E) 6 EUROPE 6.1 Europe Market Growth 6.2 Europe Market by Countries 6.3 Major Countries Market Growth 6.3.1 Germany Market Size and Growth (2016-2021E) 6.3.2 UK Market Size and Growth (2016-2021E) 6.3.3 France Market Size and Growth (2016-2021E) 6.3.4 Russia Market Size and Growth (2016-2021E) 6.3.5 Italy Market Size and Growth (2016-2021E) 6.3.6 Rest of Europe Market Size and Growth (2016-2021E) 7 ASIA-PACIFIC 7.1 ASIA-PACIFIC Market Growth 7.2 ASIA-PACIFIC Market by Countries 7.3 Major Countries Market Growth 7.3.1 China Market Size and Growth (2016-2021E) 7.3.2 India Market Size and Growth (2016-2021E) 7.3.3 Japan Market Size and Growth (2016-2021E) 7.3.4 South Korea Market Size and Growth (2016-2021E) 7.3.5 Southeast Asia Market Size and Growth (2016-2021E) 7.3.6 Australia Market Size and Growth (2016-2021E) 7.3.7 Rest of Asia Pacific Market Size and Growth (2016-2021E) 8 SOUTH AMERICA 8.1 South America Market Growth 8.2 South America Market by Countries 8.3 Major Countries Market Growth 8.3.1 Brazil Market Size and Growth (2016-2021E) 8.3.2 Argentina Market Size and Growth (2016-2021E) 8.3.3 Rest of South America Market Size and Growth (2016-2021E) 9 MIDDLE EAST & AFRICA 9.1 Middle East and Africa Market Growth 9.2 Middle East and Africa Market by Countries 9.3 Major Countries Market Growth 9.3.1 GCC Market Size and Growth (2016-2021E) 9.3.2 North Africa Market Size and Growth (2016-2021E) 9.3.3 South Africa Market Size and Growth (2016-2021E) 9.3.4 Rest of Middle East & Africa Market Size and Growth (2016-2021E) 10 MARKET FORECAST 10.1 Global Market Forecast Overview 10.2 Global Market Forecast by Type 10.3 Global Market Forecast by Application / End-Use 10.4 Global Market Forecast by Region 11 COMPETITION OF MAJOR PLAYERS 11.1 Boehringer Ingelheim (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.1.1 Boehringer Ingelheim Profile 11.1.2 Boehringer Ingelheim Products & Services Overview 11.1.3 Boehringer Ingelheim Main Business 11.1.4 Boehringer Ingelheim Business Operation 11.2 Cerenis Therapeutics (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.2.1 Cerenis Therapeutics Profile 11.2.2 Cerenis Therapeutics Products & Services 11.2.3 Cerenis Therapeutics Main Business 11.2.4 Cerenis Therapeutics Business Operation 11.3 Connexios Life Sciences (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.3.1 Connexios Life Sciences Profile 11.3.2 Connexios Life Sciences Products & Services 11.3.3 Connexios Life Sciences Main Business 11.3.4 Connexios Life Sciences Business Operation 11.4 Genfit (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.4.1 Genfit Profile 11.4.2 Genfit Products & Services 11.4.3 Genfit Main Business 11.4.4 Genfit Business Operation 11.5 Islet Sciences (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.5.1 Islet Sciences Profile 11.5.2 Islet Sciences Products & Services 11.5.3 Islet Sciences Main Business 11.5.4 Islet Sciences Business Operation 11.6 Nimbus Therapeutics (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.6.1 Nimbus Therapeutics Profile 11.6.2 Nimbus Therapeutics Products & Services 11.6.3 Nimbus Therapeutics Main Business 11.6.4 Nimbus Therapeutics Business Operation 11.7 Verva Pharmaceuticals (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.7.1 Verva Pharmaceuticals Profile 11.7.2 Verva Pharmaceuticals Products & Services 11.7.3 Verva Pharmaceuticals Main Business 11.7.4 Verva Pharmaceuticals Business Operation 11.8 Viking Therapeutics (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.8.1 Viking Therapeutics Profile 11.8.2 Viking Therapeutics Products & Services 11.8.3 Viking Therapeutics Main Business 11.8.4 Viking Therapeutics Business Operation 11.9 Astazeneca Plc (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.9.1 Astazeneca Plc Profile 11.9.2 Astazeneca Plc Products & Services 11.9.3 Astazeneca Plc Main Business 11.9.4 Astazeneca Plc Business Operation 11.10 Galmed Pharmaceuticals (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.10.1 Galmed Pharmaceuticals Profile 11.10.2 Galmed Pharmaceuticals Products & Services 11.10.3 Galmed Pharmaceuticals Main Business 11.10.4 Galmed Pharmaceuticals Business Operation 11.11 GENFIT SA (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.11.1 GENFIT SA Profile 11.11.2 GENFIT SA Products & Services 11.11.3 GENFIT SA Main Business 11.11.4 GENFIT SA Business Operation 11.12 Gilead Science (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.12.1 Gilead Science Profile 11.12.2 Gilead Science Products & Services 11.12.3 Gilead Science Main Business 11.12.4 Gilead Science Business Operation 11.13 Novo Nordisk (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.13.1 Novo Nordisk Profile 11.13.2 Novo Nordisk Products & Services 11.13.3 Novo Nordisk Main Business 11.13.4 Novo Nordisk Business Operation 11.14 Immuron (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.14.1 Immuron Profile 11.14.2 Immuron Products & Services 11.14.3 Immuron Main Business 11.14.4 Immuron Business Operation 11.15 Intercepts Pharmaceuticals (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.15.1 Intercepts Pharmaceuticals Profile 11.15.2 Intercepts Pharmaceuticals Products & Services 11.15.3 Intercepts Pharmaceuticals Main Business 11.15.4 Intercepts Pharmaceuticals Business Operation 11.16 Enzo Biochem (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.16.1 Enzo Biochem Profile 11.16.2 Enzo Biochem Products & Services 11.16.3 Enzo Biochem Main Business 11.16.4 Enzo Biochem Business Operation 11.17 Tobira Therapeutics (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.17.1 Tobira Therapeutics Profile 11.17.2 Tobira Therapeutics Products & Services 11.17.3 Tobira Therapeutics Main Business 11.17.4 Tobira Therapeutics Business Operation 12 COMPANY COMPETITION 12.1 Global Sales by Company 12.1.1 Global Sales by Company 12.1.2 Global Sales Share by Company 12.2 Price & Gross Margin 12.3 Landscape of Major Companies in the Market 12.3.1 Major Companies Product Type List 12.3.1 Manufacturing Regions and Headquarters of Major Companies 12.3.1 Mergers & Acquisitions 12.4 Competitive Environment for New Entrants 12.4.1 Michael Porter's Five Forces Model 12.4.2 SWOT 13 ENVIRONMENT OVERVIEW 13.1 Impact of COVID-19 13.2 Geopolitics Overview 13.3 Economic Overview of Major Countries 14 RESEARCH CONCLUSION
LIST OF TABLE TABLE ~ Nonalcoholic Steatohepatitis (NASH) Industry Dynamics & Regulations List TABLE ~ Global Nonalcoholic Steatohepatitis (NASH) Sales Volume, Revenue, Price, Cost and Margin, 2016-2021E TABLE ~ Weight Loss Treatment Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Weight Loss Treatment Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Insulin-Sensitizing Agents Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Insulin-Sensitizing Agents Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Lipid-Lowering Drugs Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Lipid-Lowering Drugs Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Antioxidants Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Antioxidants Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Others Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Others Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Global Nonalcoholic Steatohepatitis (NASH) Market Size by Type, 2016-2021E, in USD Million TABLE ~ Global Nonalcoholic Steatohepatitis (NASH) Market Size by Type, 2016-2021E, in Volume TABLE ~ Hospitals Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Hospitals Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Clinics Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Clinics Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Research Institute Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Research Institute Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Others Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Others Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Global Nonalcoholic Steatohepatitis (NASH) Market Size by Type, 2016-2021E, in USD Million TABLE ~ Global Nonalcoholic Steatohepatitis (NASH) Market Size by Type, 2016-2021E, in Volume TABLE ~ North America Nonalcoholic Steatohepatitis (NASH) Sales by Countries 2016-2021E, in USD Million TABLE ~ North America Nonalcoholic Steatohepatitis (NASH) Sales Share by Countries 2016-2021E, in USD Million TABLE ~ North America Nonalcoholic Steatohepatitis (NASH) Sales by Countries 2016-2021E, in Volume TABLE ~ North America Nonalcoholic Steatohepatitis (NASH) Sales Share by Countries 2016-2021E, in Volume TABLE ~ United States Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Canada Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Mexico Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Europe Nonalcoholic Steatohepatitis (NASH) Sales by Countries 2016-2021E, in USD Million TABLE ~ Europe Nonalcoholic Steatohepatitis (NASH) Sales Share by Countries 2016-2021E, in USD Million TABLE ~ Europe Nonalcoholic Steatohepatitis (NASH) Sales by Countries 2016-2021E, in Volume TABLE ~ Europe Nonalcoholic Steatohepatitis (NASH) Sales Share by Countries 2016-2021E, in Volume TABLE ~ Germany Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ UK Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ France Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Russia Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Italy Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Rest of Europe Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ ASIA-PACIFIC Nonalcoholic Steatohepatitis (NASH) Sales by Countries 2016-2021E, in USD Million TABLE ~ ASIA-PACIFIC Nonalcoholic Steatohepatitis (NASH) Sales Share by Countries 2016-2021E, in USD Million TABLE ~ ASIA-PACIFIC Nonalcoholic Steatohepatitis (NASH) Sales by Countries 2016-2021E, in Volume TABLE ~ ASIA-PACIFIC Nonalcoholic Steatohepatitis (NASH) Sales Share by Countries 2016-2021E, in Volume TABLE ~ China Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ India Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Japan Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ South Korea Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Southeast Asia Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Australia Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Rest of Asia Pacific Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ South America Nonalcoholic Steatohepatitis (NASH) Sales by Countries 2016-2021E, in USD Million TABLE ~ South America Nonalcoholic Steatohepatitis (NASH) Sales Share by Countries 2016-2021E, in USD Million TABLE ~ South America Nonalcoholic Steatohepatitis (NASH) Sales by Countries 2016-2021E, in Volume TABLE ~ South America Nonalcoholic Steatohepatitis (NASH) Sales Share by Countries 2016-2021E, in Volume TABLE ~ Brazil Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Argentina Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Rest of South America Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Sales by Countries 2016-2021E, in USD Million TABLE ~ Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Sales Share by Countries 2016-2021E, in USD Million TABLE ~ Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Sales by Countries 2016-2021E, in Volume TABLE ~ Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Sales Share by Countries 2016-2021E, in Volume TABLE ~ GCC Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ North Africa Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ South Africa Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Rest of Middle East & Africa Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Global Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Type 2022F-2026F, in USD Million TABLE ~ Global Nonalcoholic Steatohepatitis (NASH) Sales Share Forecast by Type 2022F-2026F, in USD Million TABLE ~ Global Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Type 2022F-2026F, in Volume TABLE ~ Global Nonalcoholic Steatohepatitis (NASH) Sales Share Forecast by Type 2022F-2026F, in Volume TABLE ~ Global Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Application / End-Use 2022F-2026F, in USD Million TABLE ~ Global Nonalcoholic Steatohepatitis (NASH) Sales Share Forecast by Application / End-Use 2022F-2026F, in USD Million TABLE ~ Global Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Application / End-Use 2022F-2026F, in Volume TABLE ~ Global Nonalcoholic Steatohepatitis (NASH) Sales Share Forecast by Application / End-Use 2022F-2026F, in Volume TABLE ~ Global Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Region 2022F-2026F, in USD Million TABLE ~ Global Nonalcoholic Steatohepatitis (NASH) Sales Share Forecast by Region 2022F-2026F, in USD Million TABLE ~ Global Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Region 2022F-2026F, in Volume TABLE ~ Global Nonalcoholic Steatohepatitis (NASH) Sales Share Forecast by Region 2022F-2026F, in Volume TABLE ~ Boehringer Ingelheim Overview List TABLE ~ Products & Services List of Boehringer Ingelheim TABLE ~ Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Cerenis Therapeutics Overview List TABLE ~ Products & Services List of Cerenis Therapeutics TABLE ~ Business Operation of Cerenis Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Connexios Life Sciences Overview List TABLE ~ Products & Services List of Connexios Life Sciences TABLE ~ Business Operation of Connexios Life Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Genfit Overview List TABLE ~ Products & Services List of Genfit TABLE ~ Business Operation of Genfit (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Islet Sciences Overview List TABLE ~ Products & Services List of Islet Sciences TABLE ~ Business Operation of Islet Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Nimbus Therapeutics Overview List TABLE ~ Products & Services List of Nimbus Therapeutics TABLE ~ Business Operation of Nimbus Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Verva Pharmaceuticals Overview List TABLE ~ Products & Services List of Verva Pharmaceuticals TABLE ~ Business Operation of Verva Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Viking Therapeutics Overview List TABLE ~ Products & Services List of Viking Therapeutics TABLE ~ Business Operation of Viking Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Astazeneca Plc Overview List TABLE ~ Products & Services List of Astazeneca Plc TABLE ~ Business Operation of Astazeneca Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Galmed Pharmaceuticals Overview List TABLE ~ Products & Services List of Galmed Pharmaceuticals TABLE ~ Business Operation of Galmed Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ GENFIT SA Overview List TABLE ~ Products & Services List of GENFIT SA TABLE ~ Business Operation of GENFIT SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Gilead Science Overview List TABLE ~ Products & Services List of Gilead Science TABLE ~ Business Operation of Gilead Science (Sales Revenue, Cost, Gross Margin) TABLE ~ Novo Nordisk Overview List TABLE ~ Products & Services List of Novo Nordisk TABLE ~ Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Immuron Overview List TABLE ~ Products & Services List of Immuron TABLE ~ Business Operation of Immuron (Sales Revenue, Cost, Gross Margin) TABLE ~ Intercepts Pharmaceuticals Overview List TABLE ~ Products & Services List of Intercepts Pharmaceuticals TABLE ~ Business Operation of Intercepts Pharmaceuticals (Sales Revenue, Cost, Gross Margin) TABLE ~ Enzo Biochem Overview List TABLE ~ Products & Services List of Enzo Biochem TABLE ~ Business Operation of Enzo Biochem (Sales Revenue, Cost, Gross Margin) TABLE ~ Tobira Therapeutics Overview List TABLE ~ Products & Services List of Tobira Therapeutics TABLE ~ Business Operation of Tobira Therapeutics (Sales Revenue, Cost, Gross Margin) TABLE ~ Global Nonalcoholic Steatohepatitis (NASH) Sales by Company 2016-2021E, in USD Million TABLE ~ Global Nonalcoholic Steatohepatitis (NASH) Sales by Company 2016-2021E, in Volume TABLE ~ Global Nonalcoholic Steatohepatitis (NASH) Sales Share by Company 2016-2021E, in USD Million TABLE ~ Global Nonalcoholic Steatohepatitis (NASH) Sales Share by Company 2016-2021E, in Volume TABLE ~ Global Nonalcoholic Steatohepatitis (NASH) Sales Price by Company 2016-2021E, in USD/Volume TABLE ~ Global Nonalcoholic Steatohepatitis (NASH) Gross Margin by Company 2016-2021E TABLE ~ Major Companies Product Type List TABLE ~ Major Companies Product Type List TABLE ~ Mergers & Acquisitions in the Market
  • PRICE
  • $3250
    $6500
    Buy Now

Our Clients